No black box warning on record for Omnaris

As of the latest FDA labeling reviewed, Omnaris (CICLESONIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Omnaris medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Epistaxis, Candida albicans infection, nasal septal perforation, impaired wound healing. Monitor patients periodically for signs of adverse effects on the nasal mucosa. Avoid spraying OMNARIS directly onto the nasal septum. Avoid use in patients with recent nasal ulcers, nasal surgery, or nasal trauma. ( 5.1 ) • Development of glaucoma or cataracts. Monitor patients cl

No black box warning on record for Omnaris

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Epistaxis, Candida albicans infection, nasal septal perforation, impaired wound healing. Monitor patients periodically for signs of adverse effects on the nasal mucosa. Avoid spraying OMNARIS directly onto the nasal septum. Avoid use in patients with recent nasal ulcers, nasal surgery, or nasal trauma. ( 5.1 ) • Development of glaucoma or cataracts. Monitor patients cl

Omnaris Black Box Warning

No black box warning on record for Omnaris

Other warnings & precautions

Omnaris Black Box Warning

No black box warning on record for Omnaris

Other warnings & precautions